Distinct types of cell death and the implication in diabetic cardiomyopathy

Y Chen, Y Hua, X Li, IM Arslan, W Zhang… - Frontiers in …, 2020 - frontiersin.org
Diabetic cardiomyopathy (DCM) is a chronic complication of diabetes mellitus, characterized
by abnormalities of myocardial structure and function. Researches on the models of type 1 …

The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders

J Di Gregorio, I Robuffo, S Spalletta… - Frontiers in cell and …, 2020 - frontiersin.org
Fibrosis is a chronic and progressive disorder characterized by excessive deposition of
extracellular matrix, which leads to scarring and loss of function of the affected organ or …

[HTML][HTML] AMP-activated protein kinase: A remarkable contributor to preserve a healthy heart against ROS injury

A Marino, DJ Hausenloy, I Andreadou… - Free Radical Biology …, 2021 - Elsevier
Heart failure is one of the leading causes of death and disability worldwide. Left ventricle
remodeling, fibrosis, and ischemia/reperfusion injury all contribute to the deterioration of …

[HTML][HTML] Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications

L Zou, M Liao, Y Zhen, S Zhu, X Chen, J Zhang… - … Pharmaceutica Sinica B, 2022 - Elsevier
Abstract UNC-51-like kinase 1 (ULK1), as a serine/threonine kinase, is an autophagic
initiator in mammals and a homologous protein of autophagy related protein (Atg) 1 in yeast …

Exosomes from induced pluripotent stem cell–derived cardiomyocytes promote autophagy for myocardial repair

MR Santoso, G Ikeda, Y Tada, JH Jung… - Journal of the …, 2020 - Am Heart Assoc
Background Induced pluripotent stem cells and their differentiated cardiomyocytes (iCM s)
have tremendous potential as patient‐specific therapy for ischemic cardiomyopathy …

Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure

K Qian, J Tang, YJ Ling, M Zhou, XX Yan, Y Xie… - …, 2023 - thelancet.com
Background Therapies are urgently required to ameliorate pathological cardiac hypertrophy
and enhance cardiac function in heart failure. Our preliminary experiments have …

Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications

T Jiang, Y Dong, W Zhu, T Wu, L Chen… - Critical Reviews in …, 2023 - Taylor & Francis
Diabetes mellitus (DM) is a chronic metabolic disease caused by a complex interaction of
genetic and environmental factors and is characterized by persistent hyperglycemia. Long …

The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets

B Jiang, X Zhou, T Yang, L Wang, L Feng… - Frontiers in …, 2023 - frontiersin.org
Autophagy is a conserved lysosomal pathway for the degradation of cytoplasmic proteins
and organelles, which realizes the metabolic needs of cells and the renewal of organelles …

[HTML][HTML] Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: pharmacology and mechanisms

X Li, L Li, W Lei, HZ Chua, Z Li, X Huang… - Biomedicine & …, 2021 - Elsevier
Cardiovascular diseases are one of the leading causes of death worldwide and cardiac
fibrosis is a common pathological process for cardiac remodeling in cardiovascular …

Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p/FOXO3

J Hu, X Wang, X Cui, W Kuang, D Li, J Wang - Cell Cycle, 2021 - Taylor & Francis
Atrial fibrillation (AF) is the common arrhythmias. Myocardial fibrosis (MF) is closely related
to atrial remodeling and leads to AF. MF is the main cause of cardiovascular diseases and a …